Showing results (1371-1380 of 1,449) with videos related to

Sort By:
Pageof 145
Cancer Research|May 20, 2004
Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3Karl-Ludwig Schaefer, Kristin Brachwitz, Daniel H Wai, et al.
NPJ Precision Oncology|September 4, 2021
Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinomaMichael Bitzer, Stephan Spahn, Sepideh Babaei, et al.
Nature Structural & Molecular Biology|December 9, 2022
A critical period of translational control during brain development at codon resolutionDermot Harnett, Mateusz C Ambrozkiewicz, Ulrike Zinnall, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 28, 2018
KIR Donor Selection: Feasibility in Identifying better DonorsDaniel Weisdorf, Sarah Cooley, Tao Wang, et al.
The EMBO Journal|February 10, 2023
Structural mechanism of CRL4-instructed STAT2 degradation via a novel cytomegaloviral DCAF receptorVu Thuy Khanh Le-Trilling, Sofia Banchenko, Darius Paydar, et al.
World Journal of Urology|February 22, 2016
Older patients with low Charlson score and high-risk prostate cancer benefit from radical prostatectomyA Sivaraman, G Ordaz Jurado, X Cathelineau, et al.
Nature Chemical Biology|April 13, 2021
Genome-wide screens uncover KDM2B as a modifier of protein binding to heparan sulfateRyan J Weiss, Philipp N Spahn, Austin W T Chiang, et al.
European Urology Open Science|August 18, 2025
Prognostic Stratification of pN1 Prostate Cancer After Radical Prostatectomy: A Competing Risk Analysis from a Multi-institutional CohortAlexander Giesen, Daimantas Milonas, Annouschka Laenen, et al.
European Urology Open Science|July 23, 2024
Risk of Cancer-related Death for Men with Biopsy Grade Group 1 Prostate Cancer and High-risk Features: A European Multi-institutional StudyDaimantas Milonas, Alexander Giesen, Tim Muilwijk, et al.
Nature Communications|January 12, 2020
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoVTimothy P Sheahan, Amy C Sims, Sarah R Leist, et al.
Pageof 145